Article Text

Download PDFPDF
Letter
Group B streptococci in milk and neonatal colonisation
  1. Alberto Berardi1,
  2. Cecilia Rossi1,
  3. Isotta Guidotti1,
  4. Andrea Zucchini2,
  5. Luigi De Carlo3,
  6. Fabrizio Ferrari1,
  7. on behalf of the GBS Prevention Working Group, Emilia-Romagna
  1. 1Terapia Intensiva Neonatale, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
  2. 2Unità Operativa di Pediatria, Ospedale Civile, Faenza, Italy
  3. 3Unità Operativa di Pediatria, Ospedale del Delta, Ferrara, Italy
  1. Correspondence to Dr Alberto Berardi, Unità Operativa di Terapia Intensiva Neonatale, Azienda Ospedaliero- Universitaria Policlinico, Via del Pozzo 71, Modena (MO) 41121, Italy; berardi.alberto{at}policlinico.mo.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We much appreciated the study by Filleron and coworkers.1 The authors analysed the literature concerning cases of group B streptococcus (GBS) late-onset disease (LOD) associated with infected milk. The presence of GBS in milk is a controversial issue and differences in definitions or methods used in some studies can lead to conflicting results. For example, some studies cited in this review provide no information concerning milk collection or milk culture methods. Most studies do not measure the bacterial inoculum, an aspect that could be crucial. Therefore, it is possible that in some cases reported in the literature, the milk was ‘contaminated’ with GBS during sampling rather than previously ‘infected’.

Filleron et …

View Full Text

Footnotes

  • Contributors AB, CR and IG drafted the manuscript; AZ and LDC participated in its design, coordination and acquisition of data and helped to draft the manuscript and FF has been involved in revising the manuscript critically for intellectual content.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Regional Ethical Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.